# Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects

Source: https://onco.cc/trials/nct00744653/  
OnCo record `nct00744653` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Electrochemotherapy in Breast cancer, run by Copenhagen University Hospital at Herlev, recorded as terminated on the registry.

## Summary

Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects is a phase 2 interventional study registered as NCT00744653 by Copenhagen University Hospital at Herlev, with 17 participants recorded, started 2008-10 and due to reach its primary completion in 2010-11. Interventions recorded: Electrochemotherapy. Conditions recorded: Breast Cancer.

Linked to the technology Electrochemotherapy because the registry names it ("electrochemotherapy") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00744653
- Phase: 2
- Setting: Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.
- Sponsor: Copenhagen University Hospital at Herlev
- Enrolled: 17

## Sources

- ClinicalTrials.gov NCT00744653: https://clinicaltrials.gov/study/NCT00744653

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- technologies: [Electrochemotherapy](https://onco.cc/technologies/electrochemotherapy/), [Electrochemotherapy devices (Cliniporator)](https://onco.cc/technologies/electrochemotherapy-devices/)

---
JSON: https://onco.cc/api/v1/entities/nct00744653.json